2,612 followers
#neoadjuvant #hepatic #arterial #infusion #chemotherapy in advanced #hepatocelluar #Cancer has a #Response rate and #diseasecontrol rate were 36.3% and 81.4%. 11.7% underwent liver resection with 5 year survival of 23% @OncoBioMed https://t.co/e9XjFB7Jnx